Clovis Oncology, Inc. short interest in 2021
In 2021, Clovis Oncology, Inc.'s disclosed short interest ran from 40.89% of shares outstanding on 15 Jan 2021 to 19.02% on 31 Dec 2021, a change of -21.87 percentage points. The year's high was 40.89% on 15 Jan 2021 and its low 19.02% on 31 Dec 2021, averaging 27.01% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.90 days on 15 Oct 2021. Full history: Clovis Oncology, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2021 in figures
- Start of year
- 40.89% (15 Jan 2021)
- End of year
- 19.02% (31 Dec 2021)
- Change
- -21.87 pp
- High
- 40.89% (15 Jan 2021)
- Low
- 19.02% (31 Dec 2021)
- Average
- 27.01%
- Highest days to cover
- 12.90 (15 Oct 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 40.89% | 7.97 | results (8-K) |
| 29 Jan 2021 | 40.86% | 2.89 | |
| 12 Feb 2021 | 31.59% | 3.60 | |
| 26 Feb 2021 | 34.63% | 4.24 | results (8-K), 10-K filed |
| 15 Mar 2021 | 33.00% | 5.28 | |
| 31 Mar 2021 | 30.84% | 1.00 | |
| 15 Apr 2021 | 30.29% | 8.73 | |
| 30 Apr 2021 | 29.13% | 10.56 | |
| 14 May 2021 | 30.06% | 6.90 | 10-Q filed, results (8-K) |
| 28 May 2021 | 29.47% | 8.48 | |
| 15 Jun 2021 | 27.40% | 2.50 | |
| 30 Jun 2021 | 26.01% | 4.64 | |
| 15 Jul 2021 | 27.08% | 4.60 | |
| 30 Jul 2021 | 24.93% | 9.84 | |
| 13 Aug 2021 | 23.54% | 10.16 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 22.95% | 8.92 | |
| 15 Sep 2021 | 21.14% | 7.18 | |
| 30 Sep 2021 | 22.48% | 8.50 | |
| 15 Oct 2021 | 21.47% | 12.90 | |
| 29 Oct 2021 | 20.46% | 12.30 | |
| 15 Nov 2021 | 20.36% | 7.90 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 20.37% | 5.97 | |
| 15 Dec 2021 | 20.16% | 6.12 | |
| 31 Dec 2021 | 19.02% | 6.55 |
See also: Clovis Oncology, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.